参考文献/References:
[1] Williams BA, Merhige ME. The prognostic association between resting heart rate and cardiac death—Myocardial perfusion defects as a potential mechanism[J].Atherosclerosis,2012,221:445-450.
[2] Opdahl A, Ambale Venkatesh B,Fernandes VR, et al. Resting heart rate as predictor for left ventricular dysfunction and heart failure: The Multi-Ethnic Study of Atherosclerosis[J].J Am Coll Cardiol,2014,63(12):1182-1189.
[3] Ogliari G, Mahinrad S, Stott DJ, et al.Resting heart rate, heart rate variability and functional decline in old age[J]. CMAJ,2015,187(15):E442-E449.
[4] Whelton SP, Narla V,Michael J, et al. Blaha association between resting heart rate and inflammatory biomarkers(high-sensitivity C-reactive protein, interleukin-6, and fibrinogen)(from the Multi-Ethnic Study of Atherosclerosis)[J]. Am J Cardiol,2014,113(4):644-649.
[5] Csiszar A, Ungvari Z, Edwards JG, et al. Endothelium-mediated control of vascular tone: COX-1 and COX-2 products[J]. Br J Pharmacol,2011,164(3):894-912.
[6] Nagae A, Fujita M, Kawarazaki H, et al. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension[J].Circulation,2009,119:978-986.
[7] Danson EJ, Li D, Wang L, et al.Targeting cardiac sympatho-vagal imbalance using gene transfer of nitric oxide synthase[J].Mol Cell Cardiol,2009,46:482-489.
[8] Thorin E, Thorin-Trescases N. Vascular endothelial ageing,heartbeat after heartbeat[J].Cardiovasc Res,2009,84:24-32.
[9] Koskinas KC, Feldman CL, Chatzizisis YS,et al. Natural history of experimental coronary atherosclerosis and vascular remodeling in relation to endothelial shear stress[J].Circulation,2010,121:2092-2101.
[10] Takumi T, Yang EH, Mathew V, et al. Coronary endothelial dysfunction is associated with a reduction in coronary artery compliance and an increase in wall shear stress[J].Heart,2010,96:773-778.
[11] Bolduc V, Drouin A,Gillis MA, et al. Heart rate-associated mechanical stress impairs carotid but not cerebral artery compliance in dyslipidemic atherosclerotic mice[J].Am J Physiol Heart Circ Physiol,2011,301:2081-2092.
[12] Palatini P, Benetos A, Julius S. Impact of increased heart rate on clinical outcomes in hypertension:implications for antihypertensive drug therapy[J]. Drugs, 2006,66:133-144.
[13] 杨琼, 武春艳, 江璐,等.剪切应力-内皮细胞-Caveolin-1信号通路在动脉粥样硬化中的作用[J].中国动脉硬化杂志,2009,17(3):237-240.
[14] Custodis F, Schirmer SH, Baumhäkel M, et al.Vascular pathophysiology in response to increased heart rate[J].J Am Coll Cardiol,2010,56:1973-1983.
[15] Levy RL, White PD, Stroud WD. Transient tachycardia: pronostic significance alone and in association with transient hypertension[J]. JAMA,1945,129:585-588.
[16] Dominguez-Rodriguez A, Blanco-Palacios G, Abreu-Gonzalez P. Increased heart rate and atherosclerosis:potential implications of ivabradine therapy[J].World J Cardiol,2011,3(4):101-104.
[17] Woodward M, Webster R, Murakami Y, et al. The association between resting heart rate, cardiovascular disease and mortality:evidence from 112,680 men and women in 12 cohorts[J]. Eur J Prev Cardiol,2014,21(6):719-726.
[18] Whelton SP, Blankstein R, Al-Mallah MH,et al.Association of resting heart rate with carotid and aortic arterial stiffness: Multi-Ethnic Study of Atherosclerosis(MESA)[J].Hypertension,2013,62(3):10.1161.
[19] Fongemie J,Felix-Getzik E.A review of nebivolol pharmacology and clinical evidence[J]. Drugs,2015,75(12):1349-1371.
[20] Park KH,Park WJ.Endothelial dysfunction:clinical implications in cardiovascular disease and therapeutic approaches[J].J Korean Med Sci,2015,30(9): 1213-1225.
[21] Seals DR, Jablonskici KL,Donato AJ. Aging and vascular endothelial function in humans[J].Clin Sci(Lond),2011,120(9):357-375.
[22] Custodis F,Baumhakel M,Schlimmer N,et al. Heart rate reduction by ivabradine reduces oxidative stress improves endothelial function and prevents atherosclerosis in apolipoprotein E-deficient mice[J].Circulation,2008,117:2377-2387.
[23] Fox K,Ford I,Steg PG,et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction(BEAUTIFUL): a randomised, double-blind, placebo-controlled trial[J].Lancet,2008,372:807-816.
[24] Swedberg K,Komajda M,Bohm M,et al. Ivabradine and outcomes in chronic heart failure(SHIFT): a randomised placebo-controlled study[J].Lancet,2010,376:875-885.
[25] Ho JE, Larson MG, Ghorbani A,et al.Long-term cardiovascular risks associated with an elevated heart rate: The Framingham Heart Study[J].J Am Heart Assoc, 2014 Jun; 3(3): e000668.
[26] Steinberg BA,Kim S,Thomas L,et al. Increased heart rate is associated with higher mortality in patients with atrial fibrillation(AF): results from the Outcomes Registry for Better Informed Treatment of AF(ORBIT-AF)[J]. J Am Heart Assoc,2015,4(9): e002031.
[27] Tarry-Adkins JL, Martin-Gronert MS, Chen JH, et al.Maternal diet influences DNA damage, aortic telomere length, oxidative stress, and antioxidant defense capacity in rats[J].FASEB,2008,22:2037-2044.